Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study
CNS Neuroscience & Therapeutics · 2023-12 · 29 (12) · 3889-3900
DOI: 10.1111/cns.14309 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 13.06.2023. Verfasst von Heng Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Parkinson Disease, Vagus Nerve Stimulation, Transcutaneous Electric Nerve Stimulation. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Social Development Project.
Abstract (Originalsprache)
Objective
In this randomized, double‐blind, sham‐controlled trial, we explored the effect of 20 Hz transcutaneous auricular vagus nerve stimulation (taVNS) on gait impairments in Parkinson's disease (PD) patients and investigated the underlying neural mechanism.
Methods
In total, 22 PD patients and 14 healthy controls were enrolled. PD patients were randomized (1:1) to receive active or sham taVNS (same position as active taVNS group but without releasing current) twice a day for 1 week. Meanwhile, all subjects were measured activation in the bilateral frontal and sensorimotor cortex during usual walking by functional near‐infrared spectroscopy.
Results
PD patients showed instable gait with insufficient range of motion during usual walking. Active taVNS improved gait characteristics including step length, stride velocity, stride length, and step length variability compared with sham taVNS after completion of the 7‐day therapy. No difference was found in the Unified Parkinson's Disease Rating Scale III, Timed Up and Go, Tinetti Balance, and Gait scores. Moreover, PD patients had higher relative change of oxyhemoglobin in the left dorsolateral prefrontal cortex, pre‐motor area, supplementary motor area, primary motor cortex, and primary somatosensory cortex than HCs group during usual walking. Hemodynamic responses in the left primary somatosensory cortex were significantly decreased after taVNS therapy. Conclusion taVNS can relieve gait impairments and remodel sensorimotor integration in PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Ke-Zhong Zhang
Förderung
- National Natural Science Foundation of China
- Jiangsu Social Development Project
Zitieren
APA
Zhang, H., Cao, X. Y., Wang, L. N., Tong, Q., Sun, H. M., Gan, C. T., Shan, A. D., Yuan, Y. S., & Zhang, K. Z. (2023). Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study. CNS Neuroscience & Therapeutics, 29(12), 3889-3900. https://doi.org/10.1111/cns.14309
Vancouver
Zhang H, Cao XY, Wang LN, Tong Q, Sun HM, Gan CT, et al. Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study. CNS Neuroscience & Therapeutics. 2023;29(12):3889-3900. doi:10.1111/cns.14309
BibTeX
@article{Zhang2023,
author = {Zhang, Heng and Cao, Xing-Yue and Wang, Li-Na and Tong, Qing and Sun, Hui-Min and Gan, Cai-Ting and Shan, Ai-di and Yuan, Yong-Sheng and Zhang, Ke-Zhong},
title = {Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
volume = {29},
number = {12},
pages = {3889--3900},
doi = {10.1111/cns.14309}
}
EUVIMED